Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease
about
Regulation of NF-κB by ubiquitinationRIP2 activity in inflammatory disease and implications for novel therapeuticsThe role of innate immunity receptors in the pathogenesis of inflammatory bowel diseaseA genome-wide small interfering RNA (siRNA) screen reveals nuclear factor-κB (NF-κB)-independent regulators of NOD2-induced interleukin-8 (IL-8) secretionLRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populationsEmerging significance of NLRs in inflammatory bowel disease.A discrete ubiquitin-mediated network regulates the strength of NOD2 signaling.TRAF molecules in cell signaling and in human diseasesRegulation where autophagy intersects the inflammasome.The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation.Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.UbiNet: an online resource for exploring the functional associations and regulatory networks of protein ubiquitylation.Role of NOD2 and RIP2 in host-microbe interactions with Gram-negative bacteria: insights from the periodontal disease model.Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.Improvement with infliximab of a disseminated sarcoidosis in a patient with Crohn's disease.Functional defects in NOD2 signaling in experimental and human Crohn disease.Synthetic Biology Reveals the Uniqueness of the RIP Kinase Domain.Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase.Casting the critical regions in nucleotide binding oligomerization domain 2 protein: a signature mediated structural dynamics approach.Association between receptor interacting serine/threonine kinase 2 polymorphisms and gastric cancer susceptibility.NOD2 and inflammation: current insights.Ubiquitination regulation of inflammatory responses through NF-κB pathway.Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis
P2860
Q27024099-113C9A54-CC30-4885-A420-306CE566C41FQ27025050-4044A61E-8F6F-4227-A76F-C49ABF0F9A3BQ27027809-60CD7182-0B12-40D4-A580-D7924A28CF81Q34317315-557AA39D-0BAD-44C3-BF23-DF0B207D5A6AQ34981661-AC980563-0BFC-4959-BF3A-29E5A657AD2EQ35414220-087CDABA-7519-4842-9DF3-18836F3DAF0CQ36506610-D6BB3756-362C-4A11-94F9-9246D14D6EEEQ36972287-5A2710DF-E32E-4BD2-B730-47A11B0862C4Q38103910-C2095FA4-B3C3-4018-A9FE-33D0A7007506Q38234947-3D47E7BE-B1E7-4701-AFA7-BE22731E46CBQ38707914-7744379C-6BF0-4D22-891A-73E4CF534E4AQ39821996-EE863619-370D-41F9-B850-CAA64CAE0B4AQ40548282-0396EDFF-10CE-438E-921B-49E1F6F7CCF4Q41692704-A5F39400-FD6D-4094-A3F7-F5A347E7E348Q41973657-13DA0452-213D-4E50-AA47-0FC4FC2EB904Q42018048-4849FBAD-BD49-48B8-80DF-03754C5ECE6DQ42784465-B7D6180C-5CA0-4974-BDD9-BB6B32795894Q47322523-337E13BF-BE31-4ABC-BBBA-2DFE74C5340CQ48952209-705ACA0E-BA3B-4419-B725-17329D8EE2D7Q50234894-A88A7B35-FA3E-46E0-8383-E29EB8FBE8BCQ55000637-1C532D38-0D61-4CC3-996B-FA5D7B04E4C4Q55328184-DEF161EC-5FEE-44E9-9468-E8A201B06A28Q57141984-39261D02-8846-44A7-B93C-018819E5B19D
P2860
Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ubiquitination and phosphoryla ...... ling and NOD2-mediated disease
@en
type
label
Ubiquitination and phosphoryla ...... ling and NOD2-mediated disease
@en
prefLabel
Ubiquitination and phosphoryla ...... ling and NOD2-mediated disease
@en
P2860
P1476
Ubiquitination and phosphoryla ...... ling and NOD2-mediated disease
@en
P2860
P304
P356
10.1016/J.BBAMCR.2012.03.017
P407
P577
2012-04-11T00:00:00Z